Results 61 to 70 of about 32,569 (155)

Management of post-transplant lymphoproliferative disorders

open access: yesHemaSphere, 2019
Daan Dierickx, Vibeke Vergote
doaj   +1 more source

A05 | TP53 in lymphoproliferative neoplastic disorders

open access: yesHaematologica
TP53 disruption represents a central event driving clonal evolution, therapeutic resistance, and adverse outcome in several B-cell neoplasms, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and diffuse large B-cell lymphoma ...
Gian Matteo Rigolin
doaj  

Polyclonal evolution of lymphoproliferative disorders in XLP1. [PDF]

open access: yesJ Hum Immun
Tomomasa D   +18 more
europepmc   +1 more source

Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS-CoV-2 Vaccination: A Systematic Review. [PDF]

open access: yesJ Skin Cancer
Mussi M   +8 more
europepmc   +1 more source

HIV-associated lymphoproliferative disorders: Single-center experience. [PDF]

open access: yesMedicine (Baltimore)
Demirtas D   +13 more
europepmc   +1 more source

JAK2 Fusions in Adult Patients With Mycosis Fungoides and CD30 Lymphoproliferative Disorders. [PDF]

open access: yesJAMA Dermatol
Geller S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy